Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

aTyr Pharma Presents Posters For Neuropilin-2 In Immune Regulation At Keystone Symposia On Myeloid Cell Diversity

Author: Benzinga Newsdesk | January 29, 2024 08:18am

 Findings further demonstrate that efzofitimod modulates myeloid cells via the neuropilin-2 (NRP2) receptor to promote a unique anti-inflammatory mechanism.

Role of NRP2 in immune system validated by activity of NRP2 blocking antibody in preclinical models.

Posted In: LIFE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist